Our research indicates that the decreased susceptibility to stroke is associated with an increase in the expression of CD40 in monocytes, particularly in CD14+ CD16+ and CD14+ CD16- monocytes, with the latter two demonstrating the most compelling evidence. This evidence concerns the gene CD40 and stroke disorder.